Can't Miss Webinar—Lupus Nephritis: The ACR Guideline in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Underwater Biosimilars Coalition Shares Results of Practice Survey with Congressional Leaders

From the College  |  May 16, 2025

This week, the Coalition sent Congressional leadership a letter detailing the results of a recent survey about how underwater biosimilars are impacting physicians’ ability to provide high-quality care. Almost all of the nearly 200 practices queried reported being  underwater on several biosimilars, with rituximab and infliximab biosimilars being the most common.

Filed under:InsuranceLegislation & AdvocacyPractice Support Tagged with:ACR advocacyBiosimilars

The Transition from a Rheumatology Fellowship to Private Practice

Tom Berry, DO  |  March 6, 2025

The transition from being a rheumatology fellow to being in private practice is significant. As I reflect on the past two years, I want to share my observations and begin a conversation about how to prepare rheumatology fellows for careers as practicing rheumatologists. The difference between learning about rheumatology and practicing rheumatology is nuanced. Upon…

Filed under:CareerCareer DevelopmentOpinionPractice SupportSpeak Out Rheum Tagged with:Fellowsrheumatologist fellows

2024 Rheumatology Fellowship Match Day Results

From the College  |  December 9, 2024

Match Day Results Highlight Continued Interest in Adult Rheumatology & Sharp Declines in Pediatric Rheumatology  The ACR applauds another successful recruitment season for rheumatology and welcomes an impressive pool of applicants to the specialty. Ninety-nine percent of adult rheumatology positions were filled for the 2024 appointment year as part of the National Resident Matching Program…

Filed under:American College of RheumatologyEducation & TrainingFrom the CollegePractice SupportProfessional TopicsWorkforce

Editor's Pick

An Approach to Physical Activity & Exercise in Axial Spondyloarthritis

Yvonne M. van der Kraan, BSc, Andrew Lui, PT, DPT, Anneke Spoorenberg, MD, Suzanne Arends, PhD, & Lianne S. Gensler, MD  |  December 9, 2024

‘Physical therapy is a mainstay of managing rheumatic diseases, but what’s the evidence, how do we monitor, and what types of therapy should we advocate?’ asks Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS. ‘Here, we provide some practical recommendations for the everyday rheumatologist.’ Physical activity, including occupational and recreational activities, is one of…

Filed under:Axial SpondyloarthritisConditions Tagged with:Editor's PickExercisePhysical Therapy

Key Research in Axial Spondyloarthritis Encapsulated

David S. Pisetsky, MD, PhD  |  December 2, 2024

Our understanding of (axSpA) has really changed, especially with regard to male-female differences. In this report, we identify important research on axSpA presented at ACR Convergence 2024, summarize the abstracts and comment on why each is important, addressing the relevance for clinicians and the potential impact on future research.

Filed under:ACR ConvergenceAxial SpondyloarthritisConditionsGuidanceMeeting Reports Tagged with:ACR Convergence 2024ACR Convergence 2024 axSpAAS Resource Center

How to Write an Effective Fellowship Application Essay

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  November 9, 2024

I read a lot of essays and, believe it or not, I’ve been known to write a few on occasion as well. The majority of them kind of linger in the back of my mind and are slowly forgotten. The ones that stick with me tend to be the application essays that I scrutinize every…

Filed under:CareerCareer DevelopmentOpinionRheuminations Tagged with:Fellowsfellowship application

Autoantibodies Illuminate Lupus Nephritis

Arthritis & Rheumatology  |  October 28, 2024

Fava et al. investigated longitudinal autoantibody profiles in patients with lupus nephritis (LN) to define serological biomarkers of histologic class. They found that baseline levels of anti-C1q and anti-double-stranded DNA antibodies may serve as noninvasive biomarkers of proliferative LN and anti-C1q antibodies may predict complete response.

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:Arthritis & RheumatologyautoantibodieskidneyLupus nephritisSLEsystemic lupus erythematosus (SLE)

ATAP Board Appointments for 2024-25 Include 2 Distinguished ACR Members

From the College  |  October 21, 2024

The Alliance for Transparent and Affordable Prescriptions’ board members for the 2024–25 cycle include Marcus Snow, MD, and Howard Blumstein, MD, who both have a strong history of volunteer leadership in the ACR.

Filed under:From the CollegeLegislation & Advocacy Tagged with:Alliance for Transparent & Affordable Prescriptions (ATAP)Volunteer

Selfie of Dr. Jason Liebowitz attending a lecture during APLAR 2024

A View from Abroad: The ACR Research Exchange Program

Natasha Yetman  |  October 17, 2024

The most recent ACR/APLAR Research Exchange Program gave participants an opportunity to visit Singapore, learn from international research presentations and create connections with colleagues they may never otherwise have met.

Filed under:Career DevelopmentEULAR/OtherMeeting ReportsProfessional Topics Tagged with:APLAR 2024

ACR-Led Coalition Working Toward Legislative Solutions for Underwater Biosimilars

From the College  |  September 21, 2024

The Underwater Biosimilars Coalition will meet with the Medicare Payment Advisory Commission to discuss concerns about inadequate reimbursement for certain biosimilars, which has limited beneficiary access to these lower-cost alternative therapies.

Filed under:Billing/CodingLegislation & AdvocacyPractice Support Tagged with:BiosimilarsMedicare reimbursement rate

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 338
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences